These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9233837)
21. New Norcantharidin Analogs: Synthesis and Anticancer Activity. Pachuta-Stec A; Szuster-Ciesielska A Arch Pharm (Weinheim); 2015 Dec; 348(12):897-907. PubMed ID: 26548647 [TBL] [Abstract][Full Text] [Related]
22. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro. Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524 [TBL] [Abstract][Full Text] [Related]
23. [Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice]. Xiong W; Tang ZY; Ren ZG; Huang XY; Jia QA; Xie XY; Shen HJ Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):804-7. PubMed ID: 24447475 [TBL] [Abstract][Full Text] [Related]
24. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564 [TBL] [Abstract][Full Text] [Related]
25. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo. Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110 [TBL] [Abstract][Full Text] [Related]
26. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism]. Fan YZ; Fu JY; Zhao ZM; Chen CQ Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):271-4. PubMed ID: 15312360 [TBL] [Abstract][Full Text] [Related]
27. Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells. Chu AC; Tsang SY; Lo EH; Fung KP Life Sci; 2001 Dec; 70(5):591-601. PubMed ID: 11811903 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of human hepatocellular carcinoma by L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vitro and in vivo. Hu QY; Li JN; Song DQ; Wang YL; Bekesi G; Weisz I; Jiang JD Int J Oncol; 2004 Nov; 25(5):1289-96. PubMed ID: 15492817 [TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice]. Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672 [TBL] [Abstract][Full Text] [Related]
31. [Studies on antitumor agents II: synthesis and anticancer activity of dehydrogenated carboncyclic analogs of norcantharidin]. Fang Y; Tian SL; Li KQ; Zhao SW; Wang ZY Yao Xue Xue Bao; 1993; 28(12):931-5. PubMed ID: 8030418 [TBL] [Abstract][Full Text] [Related]
32. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy]. Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334 [TBL] [Abstract][Full Text] [Related]
33. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice. Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640 [TBL] [Abstract][Full Text] [Related]
34. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Yan Z; Yang K; Tang X; Bi Y; Ding Y; Deng M; Xia D; Zhao Y; Chen T J Immunol Res; 2022; 2022():3851604. PubMed ID: 35497873 [TBL] [Abstract][Full Text] [Related]
35. Cisplatin plus norcantharidin alter the expression of TGF-β1/Smads signaling pathway in hepatocellular carcinoma. Li KY; Shi CX; Huang JZ; Tang KL Bratisl Lek Listy; 2017; 118(2):85-88. PubMed ID: 28814088 [TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone) amphiphilic block copolymer micelles. Chen SF; Lu WF; Wen ZY; Li Q; Chen JH Pharmazie; 2012 Sep; 67(9):781-8. PubMed ID: 23016451 [TBL] [Abstract][Full Text] [Related]
37. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate]. Wang F; Li S; Lin J Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974 [TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice. Hann HW; Stahlhut MW; Rubin R; Maddrey WC Cancer; 1992 Oct; 70(8):2051-6. PubMed ID: 1327484 [TBL] [Abstract][Full Text] [Related]
39. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma. Jiang Z; Chi J; Han B; Liu W Carbohydr Polym; 2017 Oct; 174():282-290. PubMed ID: 28821069 [TBL] [Abstract][Full Text] [Related]
40. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms]. Fan YZ; Chen CQ; Zhao ZM; Sun W Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]